Rosuvastatin and Glecaprevir/Pibrentasvir Interaction

Drug interaction information between Rosuvastatin and Glecaprevir/Pibrentasvir.

Rosuvastatin and Glecaprevir/Pibrentasvir have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Rosuvastatin and Glecaprevir/Pibrentasvir. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Rosuvastatin

HMG-CoA Reductase Inhibitor (Statin)

Drug B

Glecaprevir/Pibrentasvir

NS3/4A/NS5A Inhibitor (HCV)

How They Interact

These drugs can cause rosuvastatin levels to rise in your body, which may increase the risk of side effects.

FDA Label Information

Simeprevir Dasabuvir/ombitasvir/paritaprevir/ritonavir Elbasvir/grazoprevir Sofosbuvir/velpatasvir Glecaprevir/pibrentasvir Atazanavir/ritonavir Lopinavir/ritonavir Initiate with rosuvastatin 5 mg once daily, and do not exceed a dose of rosuvastatin 10 mg once daily.

Frequently Asked Questions

What SPL severity band is on file for Rosuvastatin + Glecaprevir/Pibrentasvir?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Glecaprevir/Pibrentasvir has 38 labeled pairs on file vs Rosuvastatin's 21. In the major band specifically: Rosuvastatin has 3 (also Sofosbuvir/Velpatasvir, Febuxostat); Glecaprevir/Pibrentasvir has 3 (also Rifampin, Rosuvastatin/Ezetimibe).

What mechanism field is on file for Rosuvastatin and Glecaprevir/Pibrentasvir?

These drugs can cause rosuvastatin levels to rise in your body, which may increase the risk of side effects.

Glecaprevir/Pibrentasvir's labeled portfolio outnumbers Rosuvastatin

SPL source-record counts only. This page's band is major · classes on file: Rosuvastatin (HMG-CoA Reductase Inhibitor (Statin)); Glecaprevir/Pibrentasvir (NS3/4A/NS5A Inhibitor (HCV)).

Rosuvastatin

3 major · 8 moderate · 10 minor · 21 total

Glecaprevir/Pibrentasvir

3 major · 9 moderate · 26 minor · 38 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.